White Paper

Understanding the RTF Letter

The business impact of the refusal-to-file (RTF) letter is significant. Research indicates receiving an RTF letter can delay the review process by an average of 17 months and possibly lead to a decrease in stock value. Read and learn how to reduce the likelihood of receiving an RTF letter. Download today for valuable, practical guidance on:

  • The RTF processes
  • Critical elements to be included for a Food & Drug Administration (FDA) review process
  • The business impact associated with receiving an RTF letter
  • Ancillary benefits associated with a proactive approach

Download the white paper

Who Should Watch?

CEU Credits

Certificate of Attendance

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now